Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInvestment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pharming Group N.V (PHAR) EPS (Weighted Average and Diluted): 2018-2024

Historic EPS (Weighted Average and Diluted) for Pharming Group N.V (PHAR) over the last 7 years, with Dec 2024 value amounting to -$0.02.

  • Pharming Group N.V's EPS (Weighted Average and Diluted) rose 180.00% to $0.00 in Q4 2024 from the same period last year, while for Dec 2024 it was -$0.04, marking a year-over-year decrease of 2.78%. This contributed to the annual value of -$0.02 for FY2024, which is 12.50% down from last year.
  • Pharming Group N.V's EPS (Weighted Average and Diluted) amounted to -$0.02 in FY2024, which was down 12.50% from -$0.02 recorded in FY2023.
  • In the past 5 years, Pharming Group N.V's EPS (Weighted Average and Diluted) registered a high of $0.06 during FY2020, and its lowest value of -$0.02 during FY2024.
  • In the last 3 years, Pharming Group N.V's EPS (Weighted Average and Diluted) had a median value of -$0.02 in 2023 and averaged -$0.01.
  • Data for Pharming Group N.V's EPS (Weighted Average and Diluted) shows a maximum YoY slumped of 184.21% (in 2023) over the last 5 years.
  • Over the past 5 years, Pharming Group N.V's EPS (Weighted Average and Diluted) (Yearly) stood at $0.06 in 2020, then crashed by 58.18% to $0.02 in 2021, then decreased by 17.39% to $0.02 in 2022, then slumped by 184.21% to -$0.02 in 2023, then declined by 12.50% to -$0.02 in 2024.